Swati Verma is currently working as a Biologist in the Division of Viral Products in the Office of Vaccines in Center for Biologics Evaluation and Research at FDA. She is responsible for providing regulatory oversight as a Chemistry Manufacturing and Control (CMC) expert for viral vaccines, from early phase of product development through final authorization or licensure and post-approval. She also has expertise in analytical and immunological assays that are used for the assessments of product quality and assessments of immune response following vaccine administration. She has been working in the agency for the past 15 years but has worked on regulatory review for the past five years.